These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 20832033)
1. [Transurethral needle ablation Prostiva for treating symptomatic benign prostatic hyperplasia: a review]. Xylinas E; Le Gal S; Descazeaud A Prog Urol; 2010 Sep; 20(8):566-71. PubMed ID: 20832033 [TBL] [Abstract][Full Text] [Related]
2. A cost comparison of medical management and transurethral needle ablation for treatment of benign prostatic hyperplasia during a 5-year period. Naslund MJ; Carlson AM; Williams MJ J Urol; 2005 Jun; 173(6):2090-3; discussion 2093. PubMed ID: 15879849 [TBL] [Abstract][Full Text] [Related]
3. Transurethral needle ablation (TUNA): histopathological, radiological and clinical studies of a new office procedure for treatment of benign prostatic hyperplasia. Schulman CC; Zlotta AR Prog Clin Biol Res; 1994; 386():479-86. PubMed ID: 7528418 [TBL] [Abstract][Full Text] [Related]
4. [Advances in minimally invasive treatment of benign prostatic hyperplasia]. Yu B; Wang Z Zhonghua Nan Ke Xue; 2007 Aug; 13(8):739-43. PubMed ID: 17918717 [TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of trials of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia. Boyle P; Robertson C; Vaughan ED; Fitzpatrick JM BJU Int; 2004 Jul; 94(1):83-8. PubMed ID: 15217437 [TBL] [Abstract][Full Text] [Related]
6. Transurethral needle ablation (TUNA): histopathological, radiological and clinical studies of a new office procedure for treatment of benign prostatic hyperplasia. Hourriez LA; Zlotta AR; Schulman CC Acta Urol Belg; 1994 Dec; 62(4):33-8. PubMed ID: 7540796 [TBL] [Abstract][Full Text] [Related]
7. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails. Rosario DJ; Phillips JT; Chapple CR J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409 [TBL] [Abstract][Full Text] [Related]
8. [Transurethral ablation (Precision Plus) in the treatment of patients with benign prostatic hyperplasia]. Mazo EB; Krivoborodov GG Urologiia; 2005; (3):12-5. PubMed ID: 16097706 [TBL] [Abstract][Full Text] [Related]
10. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia. Bruskewitz R; Issa MM; Roehrborn CG; Naslund MJ; Perez-Marrero R; Shumaker BP; Oesterling JE J Urol; 1998 May; 159(5):1588-93; discussion 1593-4. PubMed ID: 9554360 [TBL] [Abstract][Full Text] [Related]
11. Durability and retreatment rates of minimal invasive treatments of benign prostatic hyperplasia: a cross-analysis of the literature. Djavan B; Eckersberger E; Handl MJ; Brandner R; Sadri H; Lepor H Can J Urol; 2010 Aug; 17(4):5249-54. PubMed ID: 20735902 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of benign prostatic hyperplasia (BPH) by transurethral needle ablation (TUNA) and 36-month follow-up of the retreatment rate]. Martin X; Claude A; Colombel M; Sarramon JP; Ballanger P; Lobel B; Richard F; Saussine C; Cavillon C; Buzelin JM; Baron JC; Lambert D; Haillot O Prog Urol; 2005 Sep; 15(4):674-80. PubMed ID: 16459684 [TBL] [Abstract][Full Text] [Related]
13. Systematic review and meta-analysis of Transurethral Needle Ablation in symptomatic Benign Prostatic Hyperplasia. Bouza C; López T; Magro A; Navalpotro L; Amate JM BMC Urol; 2006 Jun; 6():14. PubMed ID: 16790044 [TBL] [Abstract][Full Text] [Related]
14. An open study on the efficacy and safety of transurethral needle ablation of the prostate in treating symptomatic benign prostatic hyperplasia: the University of Florida experience. Kahn SA; Alphonse P; Tewari A; Narayan P J Urol; 1998 Nov; 160(5):1695-700. PubMed ID: 9783934 [TBL] [Abstract][Full Text] [Related]
15. Transurethral needle ablation of the prostate (TUNA): pathological, radiological and clinical study of a new office procedure for treatment of benign prostatic hyperplasia using low-level radiofrequency energy. Schulman C; Zlotta A Arch Esp Urol; 1994 Nov; 47(9):895-901. PubMed ID: 7530946 [TBL] [Abstract][Full Text] [Related]
16. Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: a neurohistochemical study. Zlotta AR; Raviv G; Peny MO; Noel JC; Haot J; Schulman CC J Urol; 1997 Mar; 157(3):894-9. PubMed ID: 9072594 [TBL] [Abstract][Full Text] [Related]
17. Minimally invasive surgery in the management of benign prostatic hyperplasia. Berardinelli F; Hinh P; Wang R Minerva Urol Nefrol; 2009 Sep; 61(3):269-89. PubMed ID: 19773728 [TBL] [Abstract][Full Text] [Related]
18. Treatment options for benign prostatic hyperplasia in older men. Miano R; De Nunzio C; Asimakopoulos AD; Germani S; Tubaro A Med Sci Monit; 2008 Jul; 14(7):RA94-102. PubMed ID: 18591930 [TBL] [Abstract][Full Text] [Related]
19. The effects of transurethral needle ablation and resection of the prostate on pressure flow urodynamic parameters: analysis of the United States randomized study. Roehrborn CG; Burkhard FC; Bruskewitz RC; Issa MM; Perez-Marrero R; Naslund MJ; Shumaker BP J Urol; 1999 Jul; 162(1):92-7. PubMed ID: 10379748 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of benign prostatic hyperplasia by radiofrequency (TUNA): a monocentric study of 28 cases treated in ambulatory surgery]. Le Gal S; Fouques Y; Mallick S; Taksin L; Le Toquin-Bernard S; Frachet O; Bensadoun H Prog Urol; 2009 May; 19(5):327-32. PubMed ID: 19393538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]